XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Schedule of Restrictions on Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
March 31,
2023		March 31,
2022
Cash and cash equivalents$321 $718 
Restricted cash82 55 
Cash, cash equivalents and restricted cash$403 $773 
Schedule of Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
March 31,
2023		March 31,
2022
Cash and cash equivalents$321 $718 
Restricted cash82 55 
Cash, cash equivalents and restricted cash$403 $773 
Schedule of Shares Used in Computing Basic and Diluted Earnings Per Share Shares used in computing basic and diluted earnings per share are as follows: 
Three Months Ended
March 31,		Six Months Ended
March 31,
 2023202220232022
Denominator (thousands of shares):
Weighted-average common shares outstanding — basic209,857 210,163 209,902 209,919 
Incremental shares issuable for stock options, common stock awards and Equity Units (a)6,263 5,765 — 6,017 
Weighted-average common shares outstanding — diluted216,120 215,928 209,902 215,936 
(a)For the three months ended March 31, 2023, 5,980 shares associated with outstanding stock option awards were excluded from the computation of diluted earnings per share because their effect was antidilutive. For the six months ended March 31, 2023, 6,348 of such shares have been excluded as such incremental shares would be antidilutive due to the net loss for the period. For the three and six months ended March 31, 2022, 6,535 shares associated with outstanding stock option awards were excluded from the computation of diluted earnings per share because their effect was antidilutive.